Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Padoan

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Current Allergy and Asthma Reports|January 8, 2026
Chronic Rhinosinusitis Optimisation of Nasal Outcomes and Scores (CHRONOS): An Italian Delphi Consensus on Long-Term Management with BiologicsEugenio De Corso, Frank Rikki Mauritz Canevari, Marco Caminati, et al.
Annals of the Rheumatic Diseases|September 21, 2023
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective studyBerengere Molina, Roberto Padoan, Maria Letizia Urban, et al.
Rheumatology Advances in Practice|March 22, 2024
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaireElena Treppo, Miriam Isola, Maria De Martino, et al.
Annals of the Rheumatic Diseases|May 15, 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patientsSara Monti, Alessandra Milanesi, Catherine Klersy, et al.
Rheumatology (Oxford, England)|April 26, 2025
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre studyPaolo Delvino, Luca Quartuccio, Joanna C Robson, et al.
Rheumatology (Oxford, England)|June 30, 2026
Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS studyJuan Molina-Collada, Sharon Cowley, Colm Kirby, et al.
Rheumatology (Oxford, England)|June 24, 2023
Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control studyJulien Culerrier, Yann Nguyen, Omer Karadag, et al.
Journal of Internal Medicine|December 10, 2025
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter studyFederica Pallotti, Camille Mettler, Matthias Papo, et al.
Journal of Autoimmunity|January 14, 2020
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictorsLuca Quartuccio, Milena Bond, Miriam Isola, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Current Allergy and Asthma Reports|January 8, 2026
Chronic Rhinosinusitis Optimisation of Nasal Outcomes and Scores (CHRONOS): An Italian Delphi Consensus on Long-Term Management with BiologicsEugenio De Corso, Frank Rikki Mauritz Canevari, Marco Caminati, et al.
Annals of the Rheumatic Diseases|September 21, 2023
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective studyBerengere Molina, Roberto Padoan, Maria Letizia Urban, et al.
Rheumatology Advances in Practice|March 22, 2024
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaireElena Treppo, Miriam Isola, Maria De Martino, et al.
Annals of the Rheumatic Diseases|May 15, 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patientsSara Monti, Alessandra Milanesi, Catherine Klersy, et al.
Rheumatology (Oxford, England)|April 26, 2025
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre studyPaolo Delvino, Luca Quartuccio, Joanna C Robson, et al.
Rheumatology (Oxford, England)|June 30, 2026
Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS studyJuan Molina-Collada, Sharon Cowley, Colm Kirby, et al.
Rheumatology (Oxford, England)|June 24, 2023
Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control studyJulien Culerrier, Yann Nguyen, Omer Karadag, et al.
Journal of Internal Medicine|December 10, 2025
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter studyFederica Pallotti, Camille Mettler, Matthias Papo, et al.
Journal of Autoimmunity|January 14, 2020
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictorsLuca Quartuccio, Milena Bond, Miriam Isola, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Pageof 8